Tapewire

Nasdaq · USD

ICUI

ICU MEDICAL INC/DE

Export transactions ↓
Tapewire entity
2385
SEC CIK
0000883984
Parsed reports
427

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202608
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2024 Filed Mar 18, 2024 20:49 UTC
Woolson DanielVP, GM-Infusion Capital
Exercise / conversionPerformance Shares · Derivative 2,923 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001698998-24-000003 · edgardoc.xml · derivative · entry 3

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,847

Underlying: Common Stock · 2,923 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F3 · derivative.exercise_date: One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:49 UTC
Woolson DanielVP, GM-Infusion Capital
Tax withholdingCommon Stock 1,294 $98.08 $126,915.52
Disclosure

SEC source: 0001698998-24-000003 · edgardoc.xml · nonDerivative · entry 2

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,609

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:49 UTC
Woolson DanielVP, GM-Infusion Capital
Exercise / conversionCommon Stock 2,923 $0.00 $0.00
Disclosure

SEC source: 0001698998-24-000003 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:46 UTC
Sousa BenChief Information Officer
Exercise / conversionCommon Stock · Derivative 1,299 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002013412-24-000004 · edgardoc.xml · derivative · entry 3

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 1,299 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:46 UTC
Sousa BenChief Information Officer
Tax withholdingCommon Stock 463 $98.08 $45,411.04
Disclosure

SEC source: 0002013412-24-000004 · edgardoc.xml · nonDerivative · entry 2

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,319

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:46 UTC
Sousa BenChief Information Officer
Exercise / conversionCommon Stock 1,299 $0.00 $0.00
Disclosure

SEC source: 0002013412-24-000004 · edgardoc.xml · nonDerivative · entry 1

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:35 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock · Derivative 3,247 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001804831-24-000002 · edgardoc.xml · derivative · entry 3

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

Underlying: Common Stock · 3,247 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:35 UTC
Bonnell Brian MichaelChief Financial Officer
Tax withholdingCommon Stock 1,780 $98.08 $174,582.40
Disclosure

SEC source: 0001804831-24-000002 · edgardoc.xml · nonDerivative · entry 2

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,954

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:35 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock 3,247 $0.00 $0.00
Disclosure

SEC source: 0001804831-24-000002 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,734

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:44 UTC
Sanzone Virginia RuthVP, General Counsel
Exercise / conversionCommon Stock · Derivative 1,624 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001669639-24-000002 · edgardoc.xml · derivative · entry 3

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,248

Underlying: Common Stock · 1,624 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:44 UTC
Sanzone Virginia RuthVP, General Counsel
Tax withholdingCommon Stock 890 $98.08 $87,291.20
Disclosure

SEC source: 0001669639-24-000002 · edgardoc.xml · nonDerivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,532

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:44 UTC
Sanzone Virginia RuthVP, General Counsel
Exercise / conversionCommon Stock 1,624 $0.00 $0.00
Disclosure

SEC source: 0001669639-24-000002 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:38 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock · Derivative 4,871 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001410442-24-000003 · edgardoc.xml · derivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,744

Underlying: Common Stock · 4,871 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:38 UTC
Jain VivekDirector · Chairman and CEO
Tax withholdingCommon Stock 2,671 $98.08 $261,971.68
Disclosure

SEC source: 0001410442-24-000003 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,593

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:38 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock 4,871 $0.00 $0.00
Disclosure

SEC source: 0001410442-24-000003 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 14, 2024 Filed Mar 14, 2024 22:13 UTC SaleCommon Stock 7,978 $101.87 $812,741.20
Disclosure

SEC source: 0001073397-24-000004 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Partnership

Disclosed balance after: 877,343

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:09 UTC SaleCommon Stock 1,522 $101.51 $154,496.70
Disclosure

SEC source: 0001073397-24-000002 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,231

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 16:16 UTC Amendment SaleCommon Stock 1,522 $101.51 $154,496.70
Disclosure

SEC source: 0001073397-24-000003 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Partnership

Disclosed balance after: 885,321

F1 · price: All shares sold were sold at the exact price disclosed.

F2 · ownership.nature: The original Form 4 filed on March 13, 2024, is being amended by this Form 4 amendment solely to correct the ownership form from Direct to Indirect and nature of indirect beneficial ownership to by Partnership.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:09 UTC SaleCommon Stock 1,890 $104.22 $196,968.05
Disclosure

SEC source: 0001073397-24-000002 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,753

F1 · price: All shares sold were sold at the exact price disclosed.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:35 UTC
Woolson DanielVP, GM-Infusion Capital
Exercise / conversionPerformance Shares · Derivative 2,020 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 10

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,020 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:35 UTC
Woolson DanielVP, GM-Infusion Capital
GrantCommon Stock · Derivative 6,459 $0.00 $0.00
Disclosure

SEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 8

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,459

Underlying: Common Stock · 6,459 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:35 UTC
Woolson DanielVP, GM-Infusion Capital
Tax withholdingCommon Stock 894 $104.52 $93,440.88
Disclosure

SEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 6

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,771

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:35 UTC
Woolson DanielVP, GM-Infusion Capital
Exercise / conversionCommon Stock 2,020 $0.00 $0.00
Disclosure

SEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 5

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:33 UTC
Sousa BenChief Information Officer
GrantCommon Stock · Derivative 2,871 $0.00 $0.00
Disclosure

SEC source: 0002013412-24-000003 · edgardoc.xml · derivative · entry 9

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,871

Underlying: Common Stock · 2,871 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:33 UTC
Sousa BenChief Information Officer
Exercise / conversionCommon Stock · Derivative 674 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002013412-24-000003 · edgardoc.xml · derivative · entry 7

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 674 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:33 UTC
Sousa BenChief Information Officer
Tax withholdingCommon Stock 240 $104.52 $25,084.80
Disclosure

SEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 6

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,483

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:33 UTC
Sousa BenChief Information Officer
Exercise / conversionCommon Stock 674 $0.00 $0.00
Disclosure

SEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 5

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:32 UTC
Voigtlander Christian B.Chief Operating Officer
Exercise / conversionPerformance Shares · Derivative 7,289 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001727477-24-000002 · edgardoc.xml · derivative · entry 12

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,289 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:32 UTC
Voigtlander Christian B.Chief Operating Officer
Exercise / conversionCommon Stock · Derivative 2,210 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001727477-24-000002 · edgardoc.xml · derivative · entry 9

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,210 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:32 UTC
Voigtlander Christian B.Chief Operating Officer
Tax withholdingCommon Stock 3,998 $104.52 $417,870.96
Disclosure

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 8

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,072

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:32 UTC
Voigtlander Christian B.Chief Operating Officer
Exercise / conversionCommon Stock 7,289 $0.00 $0.00
Disclosure

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 7

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:32 UTC
Voigtlander Christian B.Chief Operating Officer
Tax withholdingCommon Stock 1,212 $104.52 $126,678.24
Disclosure

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 6

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,781

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:32 UTC
Voigtlander Christian B.Chief Operating Officer
Exercise / conversionCommon Stock 2,210 $0.00 $0.00
Disclosure

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 5

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,993

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:28 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionPerformance Shares · Derivative 7,289 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 12

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,289 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:28 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock · Derivative 2,210 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 9

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,210 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:28 UTC
Bonnell Brian MichaelChief Financial Officer
Tax withholdingCommon Stock 3,998 $104.52 $417,870.96
Disclosure

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 8

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,487

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:28 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock 7,289 $0.00 $0.00
Disclosure

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 7

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:28 UTC
Bonnell Brian MichaelChief Financial Officer
Tax withholdingCommon Stock 1,212 $104.52 $126,678.24
Disclosure

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 6

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,196

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:28 UTC
Bonnell Brian MichaelChief Financial Officer
Exercise / conversionCommon Stock 2,210 $0.00 $0.00
Disclosure

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 5

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:26 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionPerformance Shares · Derivative 8,331 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 13

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,331 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:26 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock · Derivative 2,525 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 10

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,525 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:26 UTC
Jain VivekDirector · Chairman and CEO
Tax withholdingCommon Stock 4,569 $104.52 $477,551.88
Disclosure

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 8

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,393

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:26 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock 8,331 $0.00 $0.00
Disclosure

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 7

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:26 UTC
Jain VivekDirector · Chairman and CEO
Tax withholdingCommon Stock 1,384 $104.52 $144,655.68
Disclosure

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 6

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,631

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:26 UTC
Jain VivekDirector · Chairman and CEO
Exercise / conversionCommon Stock 2,525 $0.00 $0.00
Disclosure

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 5

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:24 UTC
Sanzone Virginia RuthVP, General Counsel
Exercise / conversionPerformance Shares · Derivative 2,273 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 11

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,273 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F9 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:24 UTC
Sanzone Virginia RuthVP, General Counsel
GrantCommon Stock · Derivative 9,568 $0.00 $0.00
Disclosure

SEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 9

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,568

Underlying: Common Stock · 9,568 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F6 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:24 UTC
Sanzone Virginia RuthVP, General Counsel
Tax withholdingCommon Stock 1,246 $104.52 $130,231.92
Disclosure

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 7

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,798

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:24 UTC
Sanzone Virginia RuthVP, General Counsel
Exercise / conversionCommon Stock 2,273 $0.00 $0.00
Disclosure

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 6

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:24 UTC
Sanzone Virginia RuthVP, General Counsel
SaleCommon Stock 3,300 $104.57 $345,088.26
Disclosure

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 5

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,771

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.